Our results show B cell-specific TF implication and epigenetic imprint in CLL-derived RS, and emphasize the previously described important role of TP53, FOXC1, NF-KB, and epigenetic regulators in oncogenic mechanisms. The gene discussed is NFKB1; the disease is B-cell chronic lymphocytic leukemia.